Evidence map›Paper›PMID 32353080›Full record

ArticlePLoS pathogens2020

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection.

Feng Hsiao, Julie Frouard, Andrea Gramatica, Guorui Xie, Sushama Telwatte, Guinevere Q Lee, Pavitra Roychoudhury, Roland Schwarzer, Xiaoyu Luo, Steven A Yukl and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Delivering CRISPR to the HIV-1 reservoirs.Frontiers in microbiology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Advances in HIV Research Using Mass Cytometry.Current HIV/AIDS reports · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Feng HsiaoGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Julie FrouardGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.ORCID 0000-0002-6296-2534
Andrea GramaticaGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Guorui XieGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Sushama TelwatteSan Francisco Veterans Affairs (VA) Medical Center and University of California, San Francisco, California, United States of America.ORCID 0000-0003-4086-5212
Guinevere Q LeeDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.ORCID 0000-0002-9412-886X
Pavitra RoychoudhuryDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-4567-8232
Roland SchwarzerGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Xiaoyu LuoGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Steven A YuklSan Francisco Veterans Affairs (VA) Medical Center and University of California, San Francisco, California, United States of America.
Sulggi LeeZuckerberg San Francisco General Hospital and the University of California, San Francisco, California, United States of America.
Rebecca HohDivision of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-5112-4220
Steven G DeeksDivision of HIV, Infectious Diseases and Global Medicine, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0001-6371-747X
R Brad JonesDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, New York, United States of America.
Marielle CavroisGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Warner C GreeneGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.
Nadia R RoanGladstone Institute of Virology and Immunology, San Francisco, California, United States of America.ORCID 0000-0002-5464-1976
Gladstone Institutes · USCornell University · USSan Francisco VA Medical Center · USUniversity of California, San Francisco · USSan Francisco General Hospital · USUniversity of Washington · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
Cell and Gene Therapy for HIV CureUM1AI126623 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JEROME, KEITH R, KIEM, HANS-PETER · 2016 to 2020
$24.2M
Project 3: Identifying plasma biomarkers predicting time to HIV rebound after treatment interruptionP01AI131374 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI ROAN, NADIA R · 2017 to 2021
$8.5M
Novel single genome approaches to determine the mechanisms of HIV latent infection in blood, gut, and lymph nodesR01DK120387 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI LICHTERFELD, MATHIAS, YUKL, STEVEN A · 2019 to 2023
$4.1M
Phenotypic and mechanistic analysis of the in vivo HIV latent reservoir by single-cell technologiesR01AI147777 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROAN, NADIA R · 2019 to 2022
$3.8M
Investigating Mechanisms of HIV Persistence in the GutR01DK108349 · NIDDK · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YUKL, STEVEN A · 2015 to 2019
$2.2M
CTL-Mediated Elimination of Replication Competent vs. Defective HIV Proviruses from Natural Latent Reservoirs: Roles of Antigen Specificity and Functional CharacteristicsR01AI131798 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI JONES, R. BRAD · 2017 to 2021
$2.1M
Elucidating the mechanism of progesterone-induced permissivity in the upperfemale reproductive tractR01AI127219 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROAN, NADIA R · 2016 to 2020
$2.1M
Understanding HIV latency reversal and clearance of infected cells in vivoR01AI132128 · NIAID · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI WONG, JOSEPH K, YUKL, STEVEN A · 2017 to 2021
$1.9M
BD FACSAria II Flow CytometerS10RR028962 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI CAVROIS, MARIELLE · 2011 to 2011
$544k
NCRR NIH HHS S10 RR028962NIAID NIH HHS P01 AI131374NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI127219NIAID NIH HHS R01 AI131798NIAID NIH HHS R01 AI132128NIAID NIH HHS R01 AI147777NIAID NIH HHS UM1 AI126623NIDDK NIH HHS R01 DK108349NIDDK NIH HHS R01 DK120387
6 · The paper itself

Abstract

The primary reservoir for HIV is within memory CD4+ T cells residing within tissues, yet the features that make some of these cells more susceptible than others to infection by HIV is not well understood. Recent studies demonstrated that CCR5-tropic HIV-1 efficiently enters tissue-derived memory CD4+ T cells expressing CD127, the alpha chain of the IL7 receptor, but rarely completes the replication cycle. We now demonstrate that the inability of HIV to replicate in these CD127-expressing cells is not due to post-entry restriction by SAMHD1. Rather, relative to other memory T cell subsets, these cells are highly prone to undergoing latent infection with HIV, as revealed by the high levels of integrated HIV DNA in these cells. Host gene expression profiling revealed that CD127-expressing memory CD4+ T cells are phenotypically distinct from other tissue memory CD4+ T cells, and are defined by a quiescent state with diminished NFκB, NFAT, and Ox40 signaling. However, latently-infected CD127+ cells harbored unspliced HIV transcripts and stimulation of these cells with anti-CD3/CD28 reversed latency. These findings identify a novel subset of memory CD4+ T cells found in tissue and not in blood that are preferentially targeted for latent infection by HIV, and may serve as an important reservoir to target for HIV eradication efforts.

Indexed as

CD4-Positive T-LymphocytesHIV-1HIV InfectionsHost-Pathogen InteractionsHumansImmunologic MemoryInterleukin-7 Receptor alpha SubunitVirus LatencyVirus ReplicationInterleukin-7 Receptor alpha Subunit

Identifiers

PMID32353080
PMCPMC7192375
OpenAlexW3021027962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.